Literature DB >> 23928928

Association between environmental tobacco smoke exposure and lung cancer susceptibility: modification by antioxidant enzyme genetic polymorphisms.

Mona Fathy1, Mai Hamed, Omnia Youssif, Nahla Fawzy, Wafa Ashour.   

Abstract

BACKGROUND: Environmental tobacco smoke (ETS) is the primary etiologic factor responsible for lung cancer. However, only 10-15 % of smokers develop lung cancer, suggesting a genetic role in modifying individual susceptibility to lung cancer. Antioxidant enzymes and genetic polymorphisms should be considered. AIM: The present study aimed to evaluate the role of antioxidant enzyme activity and genetic polymorphisms in modifying the susceptibility to lung cancer among individuals exposed to ETS. SUBJECTS AND METHODS: A total of 150 male subjects were divided into three groups: 50 lung cancer patients, 50 chronic smokers, and 50 passive smokers. Genotyping of microsomal epoxide hydrolase (mEH) exon 3 (Tyr(113)Hist) and exon 4 (Hist(139)Arg) polymorphisms were done by the polymerase chain reaction-restriction fragment length polymorphism technique. MnSOD (Val(16)Ala) polymorphism was detected by the real time-TaqMan assay. Erythrocyte MnSOD activity was measured spectrophotometrically.
RESULTS: ETS-exposed individuals (both active and passive smokers) who carried the His allele of mEH exon3 have a 2.9-fold increased risk of lung cancer (odds ratio [OR] 2.9, P < 0.001). In addition, ETS-exposed carriers of the Arg allele of mEH exon 4 have a 2.1-fold increased risk of lung cancer (OR 2.1, P = 0.024). However, no association between the MnSOD Val(16)Ala polymorphism and lung cancer was detected among ETS-exposed individuals (OR 1.6, P = 0.147), although the lung cancer group had significantly lower MnSOD activity than the chronic or passive smoker groups (P = 0.03).
CONCLUSIONS: Exons 3 and 4 polymorphisms of the mEH gene may contribute to lung cancer susceptibility through disturbed antioxidant balance. However, this was not the case with the MnSOD Val(16)Ala single-nucleotid polymorphism. Antioxidant enzymes may modulate the influence of ETS exposure on lung cancer risk.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 23928928     DOI: 10.1007/s40291-013-0051-6

Source DB:  PubMed          Journal:  Mol Diagn Ther        ISSN: 1177-1062            Impact factor:   4.074


  35 in total

Review 1.  EPHX1 polymorphisms and the risk of lung cancer: a HuGE review.

Authors:  Chikako Kiyohara; Kouichi Yoshimasu; Koichi Takayama; Yoichi Nakanishi
Journal:  Epidemiology       Date:  2006-01       Impact factor: 4.822

2.  Rapid and simple method for purification of nucleic acids.

Authors:  R Boom; C J Sol; M M Salimans; C L Jansen; P M Wertheim-van Dillen; J van der Noordaa
Journal:  J Clin Microbiol       Date:  1990-03       Impact factor: 5.948

3.  Frequent silence of chromosome 9p, homozygous DOCK8, DMRT1 and DMRT3 deletion at 9p24.3 in squamous cell carcinoma of the lung.

Authors:  Ji Un Kang; Sun Hoe Koo; Kye Chul Kwon; Jong Woo Park
Journal:  Int J Oncol       Date:  2010-08       Impact factor: 5.650

4.  Low activity of manganese superoxide dismutase (MnSOD) in blood of lung cancer patients with smoking history: relationship to oxidative stress.

Authors:  Ay Ly Margaret; Elisna Syahruddin; Septelia Inawati Wanandi
Journal:  Asian Pac J Cancer Prev       Date:  2011

5.  Association of functionally important polymorphism of microsomal epoxide hydrolase gene (EPHX1) with lung cancer susceptibility.

Authors:  Anup R Tilak; Sachin Kumar; Meenu Jain; Mohan C Pant; Bhudev C Das; Randeep Guleria; Balraj Mittal; Neeraj Mathur; Ashwani Kumar
Journal:  Cancer Invest       Date:  2011-07       Impact factor: 2.176

6.  The manganese superoxide dismutase Ala16Val dimorphism modulates both mitochondrial import and mRNA stability.

Authors:  Angela Sutton; Audrey Imbert; Anissa Igoudjil; Véronique Descatoire; Sophie Cazanave; Dominique Pessayre; Françoise Degoul
Journal:  Pharmacogenet Genomics       Date:  2005-05       Impact factor: 2.089

7.  Genetic analysis of microsomal epoxide hydrolase gene and its association with lung cancer risk.

Authors:  J Y Park; L Chen; A Elahi; P Lazarus; M S Tockman
Journal:  Eur J Cancer Prev       Date:  2005-06       Impact factor: 2.497

8.  Genetic polymorphism of microsomal epoxide hydrolase enzyme gene in preeclamptic females.

Authors:  Mennat Allah Kamal; Zainab Ali Elsaadany; Nevien Bahaa Fouad; Asmaa Ahmed A Elaal; Manal Mohamed Makhlouf; Mona Mohamed Shabaan; Dalia Roshdi A Elrahman
Journal:  Am J Med Sci       Date:  2012-04       Impact factor: 2.378

Review 9.  Chronic obstructive pulmonary disease and lung cancer: new molecular insights.

Authors:  Ian M Adcock; Gaetano Caramori; Peter J Barnes
Journal:  Respiration       Date:  2011-03-24       Impact factor: 3.580

10.  Association of microsomal epoxide hydrolase polymorphisms and lung cancer risk.

Authors:  A Gsur; T Zidek; K Schnattinger; E Feik; G Haidinger; P Hollaus; A Mohn-Staudner; C Armbruster; S Madersbacher; G Schatzl; K Trieb; C Vutuc; M Micksche
Journal:  Br J Cancer       Date:  2003-08-18       Impact factor: 7.640

View more
  7 in total

1.  Association between EPHX1 rs1051740 and lung cancer susceptibility: a meta-analysis.

Authors:  Peng Zhang; Youzhi Zhang; Haihua Yang; Wenjing Li; Xiaodong Chen; Feng Long
Journal:  Int J Clin Exp Med       Date:  2015-10-15

2.  Correlation between metabolic enzyme GSTP1 polymorphisms and susceptibility to lung cancer.

Authors:  Yufei Wang; B U Ren; Lei Zhang; Zhanlin Guo
Journal:  Exp Ther Med       Date:  2015-07-30       Impact factor: 2.447

Review 3.  Microsomal epoxide hydrolase 1 (EPHX1): Gene, structure, function, and role in human disease.

Authors:  Radka Václavíková; David J Hughes; Pavel Souček
Journal:  Gene       Date:  2015-07-26       Impact factor: 3.688

4.  The Genetic Heterogeneity among Different Mouse Strains Impacts the Lung Injury Potential of Multiwalled Carbon Nanotubes.

Authors:  Xiang Wang; Yu-Pei Liao; Donatello Telesca; Chong Hyun Chang; Tian Xia; André E Nel
Journal:  Small       Date:  2017-07-05       Impact factor: 13.281

5.  Association of matrix metalloproteinase-3 -1171(5A>6A) polymorphism with cancer risk: a meta-analysis of 41 studies.

Authors:  Xin Yang; Jing-Wen Hu; Man-Tang Qiu; Ming Li; Rong Yin; Jie Wang; Lin Xu; Qin Zhang
Journal:  PLoS One       Date:  2014-01-29       Impact factor: 3.240

6.  Synchronous bone metastasis in lung cancer: retrospective study of a single center of 15,716 patients from Tianjin, China.

Authors:  Xu Guo; Wenjuan Ma; Haixiao Wu; Yao Xu; Dezheng Wang; Shuang Zhang; Zheng Liu; Vladimir P Chekhonin; Karl Peltzer; Jin Zhang; Xin Wang; Chao Zhang
Journal:  BMC Cancer       Date:  2021-05-26       Impact factor: 4.430

Review 7.  Regulation of cardiovascular biology by microsomal epoxide hydrolase.

Authors:  Matthew L Edin; Darryl C Zeldin
Journal:  Toxicol Res       Date:  2021-01-21
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.